MedPath

To see the Effect of Telmisartan and Telmisartan in combination with Hydrochlorthiazide on kidney functions and serum electrolytes in patients of Essential Hypertensio

Not Applicable
Conditions
Health Condition 1: null- Essential Hypertension
Registration Number
CTRI/2018/01/011091
Lead Sponsor
Atul Patel
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients across both the genders in the Age Group 20-70 years with essential hypertension.

Exclusion Criteria

1. Patients under the age of 20 years and above 70 years.

2. patients with secondary hypertension.

3. Hypertensive patients on antihypertensive affecting serum uric acid and serum potassium levels.

4. Hyperuricemic (male >7mg/dl female >5.7mg/dl) and patients on Hyperuricemic drugs(eg.Diuretics,betablockers,pyrazinamide,ethambutol, cyclosporin, levodopa,ritonavir etc.) 5. pregnant and nursing women, patients of CLD,CKD (serum creatinine >1.5 mg/dl. eGFR <60%)

6. Hyperkalemic patient (k > 5.5mg/dl) and patients on drugs causing hyperkalemia

7. Patients not willing to participate.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction In blood pressure. change in uric acid and serum potassium levelsTimepoint: 1 and a half years
Secondary Outcome Measures
NameTimeMethod
Reduction In blood pressure. change in uric acid and serum potassium levelsTimepoint: one and a half years
© Copyright 2025. All Rights Reserved by MedPath